MKI67 and neoplasm: Since DLL1 promotes tumor cell proliferation [17], and Dl1.72 decreases MCF-7 cell proliferation in vitro (Figure 3a–c), we assessed tumor cell proliferation in tumor sections stained with Ki67 antibody.